Biofarm registers a net profit of RON 43,6 million in the first six months of the year, increasing by 20%

Biofarm (stock symbol BIO), one of the most important drug manufacturers in Romania, reports significant increases in the first half of the year compared to the same period of 2021: turnover increasing by 17% and a net profit of RON 43.6 million, up by 20%. In addition, Biofarm recorded EBITDA...

If you want to read the entire content, you
need a subscription to Nine O'Clock
This content is for subscriber members only.
Subscribe now

Only 59 euros / month or 400 euros / year (VAT not included)

Get access to:

120.000 articles in 32 years of Nine O`Clock 600 new articles every month No ads experience on the website Do you already have an subscriber account? Enter in your account here: Login
Girl in a jacket

Related posts

Adobe Romania has received the Great Place to Work certification, awarded to companies appreciated by employees


Former FinMin Ionut Misa is the new head of the Fiscal Administration. President Iohannis: I was a little surprised

Nine O' Clock

Romania –Israel Business Forum: President Rivlin pleading for Romanian-Israeli healthcare, defence technology co-operation

WP2Social Auto Publish Powered By :